Theriva BiologicsTOVX
13F holders, Q2 2025 (June 30)17holders +7
7new positions
0sold out
1famous investor
$0.43avg. 13F price*
At the end of Q2 2025, 17 institutions reported holding Theriva Biologics Inc. (TOVX) in their 13F filings, up 7 from Q1 2025. 7 opened new positions and 0 sold out. The largest holders were Ikarian Capital, LLC ($52K), Citadel Advisors ($16K) and Boothbay Fund Management, LLC ($15K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Theriva Biologics Inc.
- CUSIP
- 87164U508
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $47K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 108,705 shares bought and 8,372 shares sold, net +100,333 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Ikarian Capital, LLC | 0.02% | No change | 120,031 | $52K |
| Citadel Advisors | 0.00% | New | 36,018 | $16K |
| Boothbay Fund Management, LLC | 0.00% | No change | 35,601 | $15K |
| Virtu Financial LLC | 0.00% | New | 34,495 | $15K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.4% | 18,601 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 17,818 | $8K |
| XTX Topco Ltd | 0.00% | New | 17,187 | $7K |
| BlackRock, Inc. | 0.00% | No change | 7,568 | $3K |
| FMR LLC | 0.00% | New | 3,000 | $1K |
| Osaic Holdings, Inc. | 0.00% | Reduce -49.8% | 444 | $190 |
| Clear Street LLC | 0.00% | New | 100 | $43 |
| Bank of America Corp. | 0.00% | Add +80.5% | 74 | $32 |
| SBI Securities Co., Ltd. | 0.00% | Add +500.0% | 60 | $26 |
| IFP Advisors, Inc | 0.00% | No change | 11 | $5 |
| Pandora Wealth, Inc. | 0.00% | New | 4 | $2 |
| Danske Bank A/S | 0.00% | No change | 1 | $0 |
| UBS Group AG | 0.00% | Reduce -100.0% | 1 | $0 |
"% of holder's portfolio" is TOVX's weight in each manager's 13F, not the share of Theriva Biologics Inc. the manager owns.